Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1955 3
1956 3
1957 1
1958 1
1959 2
1960 1
1962 1
1963 2
1965 1
1969 1
1970 1
1971 2
1972 1
1973 1
1974 2
1975 2
1976 5
1977 1
1978 4
1979 3
1980 1
1981 2
1982 3
1983 1
1984 3
1985 1
1986 4
1987 2
1988 3
1989 2
1990 3
1991 1
1992 3
1993 1
1994 4
1995 5
1996 1
1997 1
1998 9
1999 3
2000 3
2001 2
2002 5
2003 4
2004 7
2005 5
2006 5
2007 9
2008 11
2009 4
2010 11
2011 8
2012 7
2013 7
2014 3
2015 5
2016 5
2017 5
2018 3
2019 7
2020 4
2021 7
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Results by year

Filters applied: . Clear all
Page 1
Phenylalanine Butyramide Is a New Cosmetic Ingredient with Soothing and Anti-Reddening Potential.
di Lorenzo R, Bernardi A, Grumetto L, Sacchi A, Avagliano C, Coppola S, de Giovanni di Santa Severina AF, Bruno C, Paparo L, Laneri S, Dini I. di Lorenzo R, et al. Molecules. 2021 Oct 31;26(21):6611. doi: 10.3390/molecules26216611. Molecules. 2021. PMID: 34771020 Free PMC article.
In contrast, some butyrate derivatives, including phenylalanine butyramide (C(13)H(18)N(2)O(2), FBA), a solid form of butyric acid, are odorless while retaining the pharmacokinetic properties and safety profile of butyric acid. ...
In contrast, some butyrate derivatives, including phenylalanine butyramide (C(13)H(18)N(2)O(2), FBA), a solid form of butyric acid, a …
Disopyramide.
[No authors listed] [No authors listed] 2023 Apr 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Apr 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000949 Free Books & Documents. Review.
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity.
Russo M, Guida F, Paparo L, Trinchese G, Aitoro R, Avagliano C, Fiordelisi A, Napolitano F, Mercurio V, Sala V, Li M, Sorriento D, Ciccarelli M, Ghigo A, Hirsch E, Bianco R, Iaccarino G, Abete P, Bonaduce D, Calignano A, Berni Canani R, Tocchetti CG. Russo M, et al. Eur J Heart Fail. 2019 Apr;21(4):519-528. doi: 10.1002/ejhf.1439. Epub 2019 Mar 6. Eur J Heart Fail. 2019. PMID: 30843309 Free article.
Here we assess whether the novel BUT derivative phenylalanine-butyramide (FBA) protects from doxorubicin (DOXO) cardiotoxicity, by decreasing oxidative stress and improving mitochondrial function. ...Furthermore, in DOXO animals, the mitochondrial degree of coupling was si …
Here we assess whether the novel BUT derivative phenylalanine-butyramide (FBA) protects from doxorubicin (DOXO) cardiotoxicity, by de …
2-[2-(2-Carb-oxy-phen-yl)hydrazinyl-idene]-3-oxo-N-phenyl-butyramide.
Dong J, Zhang G, Guo M, Wu C, Ren J. Dong J, et al. Acta Crystallogr Sect E Struct Rep Online. 2011 Dec 1;67(Pt 12):o3408. doi: 10.1107/S1600536811048173. Epub 2011 Nov 23. Acta Crystallogr Sect E Struct Rep Online. 2011. PMID: 22199894 Free PMC article.
N-(Benzothia-zol-2-yl)butyramide.
Saeed S, Bhatti MH, Jones PG. Saeed S, et al. Acta Crystallogr Sect E Struct Rep Online. 2008 Jul 12;64(Pt 8):o1486. doi: 10.1107/S1600536808020667. Acta Crystallogr Sect E Struct Rep Online. 2008. PMID: 21203198 Free PMC article.
N-(4-Chloro-phen-yl)-4-(2-oxocyclo-pent-yl)butyramide.
Yu LT, Wei JT, Zhou XG. Yu LT, et al. Acta Crystallogr Sect E Struct Rep Online. 2008 Dec 20;65(Pt 1):o162. doi: 10.1107/S1600536808042505. Acta Crystallogr Sect E Struct Rep Online. 2008. PMID: 21581619 Free PMC article.
N-(1-carbamoyl-2-phenylethyl) butyramide reduces antibiotic-induced intestinal injury, innate immune activation and modulates microbiota composition.
Lama A, Annunziata C, Coretti L, Pirozzi C, Di Guida F, Nitrato Izzo A, Cristiano C, Mollica MP, Chiariotti L, Pelagalli A, Lembo F, Meli R, Mattace Raso G. Lama A, et al. Sci Rep. 2019 Mar 18;9(1):4832. doi: 10.1038/s41598-019-41295-x. Sci Rep. 2019. PMID: 30886232 Free PMC article.
This study aimed at determining the beneficial effect of N-(1-carbamoyl-2-phenylethyl) butyramide (FBA), a butyrate releasing compound, in ceftriaxone-induced intestinal injury. ...
This study aimed at determining the beneficial effect of N-(1-carbamoyl-2-phenylethyl) butyramide (FBA), a butyrate releasing compoun …
Bench scale production of butyramide using free and immobilized cells of Bacillus sp. APB-6.
Singh R, Pandey D, Devi N, Chand D. Singh R, et al. Bioprocess Biosyst Eng. 2018 Aug;41(8):1225-1232. doi: 10.1007/s00449-018-1951-y. Epub 2018 May 10. Bioprocess Biosyst Eng. 2018. PMID: 29748858
In a 1-l batch reaction, complete conversion of 3000 mM butyronitrile to butyramide was achieved using free and immobilized cells. Immobilization of the cells further enhanced their operational stability and reusability in repetitive cycles of butyramide production. …
In a 1-l batch reaction, complete conversion of 3000 mM butyronitrile to butyramide was achieved using free and immobilized cells. Im …
3-amino-4-hydroxy-L(-)-butyramide hydrochloride.
Keresztesy JC Jr, Zambito AJ, Babson RD. Keresztesy JC Jr, et al. J Med Chem. 1971 Nov;14(11):1142-3. doi: 10.1021/jm00293a043. J Med Chem. 1971. PMID: 5115229 No abstract available.
In vivo bioavailability and in vitro toxicological evaluation of the new butyric acid releaser N-(1-carbamoyl-2-phenyl-ethyl) butyramide.
Russo R, Santarcangelo C, Badolati N, Sommella E, De Filippis A, Dacrema M, Campiglia P, Stornaiuolo M, Daglia M. Russo R, et al. Biomed Pharmacother. 2021 May;137:111385. doi: 10.1016/j.biopha.2021.111385. Epub 2021 Feb 27. Biomed Pharmacother. 2021. PMID: 33761606 Free article.
Unfortunately, unpleasant sensorial properties and unfavourable physico-chemical properties strongly limit its use in food supplements and foods for medicinal purposes. N-(1-carbamoyl-2-phenyl-ethyl) butyramide (FBA) is a new butyric acid releaser in solid form with neutra …
Unfortunately, unpleasant sensorial properties and unfavourable physico-chemical properties strongly limit its use in food supplements and f …
209 results